Mozart's rhythm influence on Alzheimer's disease progression via modulation of pathological damage and cognition
- PMID: 40792034
- PMCID: PMC12335960
- DOI: 10.1016/j.isci.2025.113168
Mozart's rhythm influence on Alzheimer's disease progression via modulation of pathological damage and cognition
Abstract
Rhythm perception is considered a conserved trait across species, and musical rhythm exposure (MRE) has been demonstrated to enhance cognitive functions in healthy individuals. Alzheimer's disease (AD), characterized by cognitive decline and pathological degeneration, may potentially be delayed by MRE. In this study, the APP/PS1 AD mouse model was exposed to Mozart's K.448 rhythm for six months, with APP/PS1 and wild-type C57BL/6J mice serving as controls. The Morris water maze test was employed to assess the impact of MRE on spatial learning and memory. Pathological damage was evaluated through amyloid-beta and phosphorylated tau levels. Additionally, hippocampal microglia activation, inflammatory markers, and gut microbiota composition were analyzed. The study revealed that MRE improves cognitive function, reduces amyloid plaque accumulation, suppresses microglial activation and neuroinflammation, and modulates gut microbiota composition. This suggests that MRE offers a promising non-pharmacological approach to slowing cognitive decline and pathological damage in AD.
Keywords: Behavioral neuroscience; Microbiome; Neuroscience.
© 2025 The Authors.
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiota.Chin Med. 2025 Aug 7;20(1):123. doi: 10.1186/s13020-025-01180-4. Chin Med. 2025. PMID: 40770806 Free PMC article.
-
Photobiomodulation modulates mitochondrial energy metabolism and ameliorates neurological damage in an APP/PS1 mousmodel of Alzheimer's disease.Alzheimers Res Ther. 2025 Apr 5;17(1):72. doi: 10.1186/s13195-025-01714-w. Alzheimers Res Ther. 2025. PMID: 40188044 Free PMC article.
-
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.Mol Neurodegener. 2024 Feb 17;19(1):18. doi: 10.1186/s13024-023-00700-w. Mol Neurodegener. 2024. PMID: 38365827 Free PMC article.
-
The effect of Mozart's K.448 on epilepsy: A systematic literature review and supplementary research on music mechanism.Epilepsy Behav. 2025 Feb;163:110108. doi: 10.1016/j.yebeh.2024.110108. Epub 2024 Dec 4. Epilepsy Behav. 2025. PMID: 39637732
-
Folic acid with or without vitamin B12 for cognition and dementia.Cochrane Database Syst Rev. 2003;(4):CD004514. doi: 10.1002/14651858.CD004514. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004514. doi: 10.1002/14651858.CD004514.pub2. PMID: 14584018 Updated.
References
-
- Samuels J.D., Moore K.A., Ennerfelt H.E., Johnson A.M., Walsh A.E., Price R.J., Lukens J.R. The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology. Alzheimers Dement. 2023;19:4908–4921. doi: 10.1002/alz.13089. - DOI - PMC - PubMed
-
- Afsaneh E., Zarei Ghobadi M. The role of neuromodulation-related technologies in neurology for the next 10 years. Brain-Apparatus Communication: A Journal of Bacomics. 2023;2 doi: 10.1080/27706710.2022.2147405. - DOI
LinkOut - more resources
Full Text Sources